These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1784459

  • 1. Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes.
    Tao RV, Holleschau AM, Rathbun WB.
    Ophthalmic Res; 1991; 23(5):272-83. PubMed ID: 1784459
    [Abstract] [Full Text] [Related]

  • 2. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
    Tao RV, Takahashi Y, Kador PF.
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF, Xu GT, Zigler S, York B.
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [Abstract] [Full Text] [Related]

  • 4. Glutathione synthesis and glutathione redox pathways in naphthalene cataract of the rat.
    Rathbun WB, Holleschau AM, Murray DL, Buchanan A, Sawaguchi S, Tao RV.
    Curr Eye Res; 1990 Jan; 9(1):45-53. PubMed ID: 1968827
    [Abstract] [Full Text] [Related]

  • 5. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
    Sato S, Sugiyama K, Lee YS, Kador PF.
    Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
    [Abstract] [Full Text] [Related]

  • 6. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF.
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [Abstract] [Full Text] [Related]

  • 7. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
    Xu GT, Zigler JS, Lou MF.
    Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
    [Abstract] [Full Text] [Related]

  • 8. Involvement of aldose reductase in naphthalene cataract.
    Lee AY, Chung SS.
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
    [Abstract] [Full Text] [Related]

  • 9. Effects of aldose reductase inhibitors on antioxidant defense in rat and rabbit liver.
    Thomas T, Rauscher F, Sanders R, Veltman J, Watkins JB.
    Toxicol Sci; 2000 Jan; 53(1):145-9. PubMed ID: 10653532
    [Abstract] [Full Text] [Related]

  • 10. Establishment of a naphthalene cataract model in vitro.
    Xu GT, Zigler JS, Lou MF.
    Exp Eye Res; 1992 Jan; 54(1):73-81. PubMed ID: 1541343
    [Abstract] [Full Text] [Related]

  • 11. Determination of AL01576 concentration in rat lenses and plasma by bioassay for aldose reductase activity measurements.
    Hockwin O, Müller P, Krolczyk J, McCue BA, Mayer PR.
    Ophthalmic Res; 1989 Jan; 21(4):285-91. PubMed ID: 2511536
    [Abstract] [Full Text] [Related]

  • 12. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
    Sato S.
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3172-8. PubMed ID: 8407226
    [Abstract] [Full Text] [Related]

  • 13. Effects of novel hydantoin derivatives with aldose reductase inhibiting activity on galactose-induced cataract in rats.
    Kato K, Nakayama K, Ohta M, Murakami N, Murakami K, Mizota M, Miwa I, Okuda J.
    Jpn J Pharmacol; 1990 Dec; 54(4):355-64. PubMed ID: 2128352
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
    Ishida H, Mitamura T, Takahashi Y, Hisatomi A, Fukuhara Y, Murato K, Ohara K.
    Toxicology; 1997 Dec 05; 123(3):167-75. PubMed ID: 9355935
    [Abstract] [Full Text] [Related]

  • 17. Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex.
    Sugiyama K, Chen Z, Lee YS, Kador PF.
    Biochem Pharmacol; 2000 Feb 15; 59(4):329-36. PubMed ID: 10644040
    [Abstract] [Full Text] [Related]

  • 18. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
    Suresha BS, Srinivasan K.
    Curr Eye Res; 2013 Oct 15; 38(10):1064-71. PubMed ID: 23767695
    [Abstract] [Full Text] [Related]

  • 19. Progression of sugar cataract in the dog.
    Sato S, Takahashi Y, Wyman M, Kador PF.
    Invest Ophthalmol Vis Sci; 1991 May 15; 32(6):1925-31. PubMed ID: 1903366
    [Abstract] [Full Text] [Related]

  • 20. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
    Sato S, Sugiyama K, Carper D.
    Adv Exp Med Biol; 1997 May 15; 414():499-505. PubMed ID: 9059655
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.